TRES, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphoma
Haematologica
.
2023 Nov 1;108(11):3110-3114.
doi: 10.3324/haematol.2023.283074.
Authors
Max J Gordon
1
,
David A Bond
2
,
Adam S Kittai
2
,
Neda Amirmokhtari
2
,
Abigail Steinbrunner
2
,
Allison Huffman
2
,
Victor Orellana-Noia
3
,
Geoffrey Shouse
4
,
Jonathon B Cohen
3
,
Tycel Phillips
4
,
Alexey V Danilov
5
Affiliations
1
University of Texas M.D. Anderson Cancer Center, Houston, TX. mjgordon@mdanderson.org.
2
Ohio State University, James Cancer Center, Columbus, OH.
3
Emory University Winship Cancer Institute, Atlanta, GA.
4
City of Hope National Medical Center, Duarte, CA.
5
City of Hope National Medical Center, Duarte, CA. adanilov@coh.org.
PMID:
37226703
PMCID:
PMC10620592
DOI:
10.3324/haematol.2023.283074
No abstract available
Publication types
Letter
MeSH terms
Adult
Aged
Comorbidity
Humans
Lymphoma, Mantle-Cell* / diagnosis
Lymphoma, Mantle-Cell* / epidemiology
Grants and funding
P30 CA016058/CA/NCI NIH HHS/United States
R01 CA244576/CA/NCI NIH HHS/United States
T32 CA009666/CA/NCI NIH HHS/United States